Overview
- TCS and AMD will co-develop industry-specific GenAI frameworks, starting with drug discovery in life sciences, cognitive quality engineering and smart manufacturing, and intelligent risk management in BFSI.
- TCS plans to integrate AMD Ryzen client CPUs for digital workplaces and deploy EPYC server CPUs, Instinct GPUs, and AI accelerators to modernize training and inference across data centers.
- Embedded AMD SoCs and FPGAs will support edge inference and industrial digitalization, extending the collaboration from cloud to factory floor and other distributed environments.
- TCS will rapidly upskill and certify employees on AMD technologies, establish centres of excellence, and jointly invest in talent to speed deployment.
- The tie-up follows TCS reporting a 17.3% sequential rise in annualised AI services revenue to $1.8 billion in Q3, while commercial terms and specific customer rollout timelines were not disclosed.